In the modified intention-to-treat analysis , tuberculosis developed in 7 of 3986 subjects in the combination-therapy group ( cumulative rate , 0.19 % ) and in 15 of 3745 subjects in the isoniazid-only group ( cumulative rate , 0.43 % ) , for a difference of 0.24 percentage points .
